Cargando…
Use of Direct-to-Consumer Telemedicine to Access Mental Health Services
BACKGROUND: The coronavirus disease 2019 pandemic has contributed to growing demand for mental health services, but patients face significant barriers to accessing care. Direct-to-consumer(DTC) telemedicine has been proposed as one way to increase access, yet little is known about its pre-pandemic u...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8799413/ https://www.ncbi.nlm.nih.gov/pubmed/35091925 http://dx.doi.org/10.1007/s11606-021-07326-y |
_version_ | 1784642062975500288 |
---|---|
author | Hohman, Jessica A. Martinez, Kathryn A. Anand, Amit Rood, Mark Martyn, Trejeeve Rose, Susannah Rothberg, Michael B. |
author_facet | Hohman, Jessica A. Martinez, Kathryn A. Anand, Amit Rood, Mark Martyn, Trejeeve Rose, Susannah Rothberg, Michael B. |
author_sort | Hohman, Jessica A. |
collection | PubMed |
description | BACKGROUND: The coronavirus disease 2019 pandemic has contributed to growing demand for mental health services, but patients face significant barriers to accessing care. Direct-to-consumer(DTC) telemedicine has been proposed as one way to increase access, yet little is known about its pre-pandemic use for mental healthcare. OBJECTIVE: To characterize patients, providers, and their use of a large nationwide DTC telemedicine platform for mental healthcare. DESIGN: Retrospective cross-sectional study. SETTING: Mental health encounters conducted on the American Well DTC telemedicine platform from 2016 to 2018. PARTICIPANTS: Patients and physicians. MAIN MEASURES: Patient measures included demographics, insurance report, and number of visits. Provider characteristics included specialty, region, and number of encounters. Encounter measures included wait time, visit length and timing, out-of-pocket payment, coupon use, prescription outcome, referral receipt, where care otherwise would have been sought, and patient satisfaction. Factors associated with five-star physician ratings and prescription receipt were assessed using logistic regression. KEY RESULTS: We analyzed 19,270 mental health encounters between 6708 patients and 1045 providers. Visits were most frequently for anxiety (39.1%) or depression (32.5%), with high satisfaction (4.9/5) across conditions. Patients had a median 2.0 visits for psychiatry (IQR 1.0–3.0) and therapy (IQR 1.0–5.0), compared to 1.0 visit (IQR 1.0–1.0) for urgent care. High satisfaction was positively correlated with prescription receipt (OR 1.89, 95% CI 1.54–2.32) and after-hours timing (aOR 1.18, 95% CI 1.02–1.36). Prescription rates ranged from 79.6% for depression to 32.2% for substance use disorders. Prescription receipt was associated with increased visit frequency (aOR 1.95, 95% CI 1.57–2.42 for ≥ 3 visits). CONCLUSIONS: As the burden of psychiatric disease grows, DTC telemedicine offers one solution for extending access to mental healthcare. While most encounters were one-off, evidence of some continuity in psychiatry and therapy visits—as well as overall high patient satisfaction—suggests potential for broader DTC telemental health use. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11606-021-07326-y. |
format | Online Article Text |
id | pubmed-8799413 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-87994132022-01-31 Use of Direct-to-Consumer Telemedicine to Access Mental Health Services Hohman, Jessica A. Martinez, Kathryn A. Anand, Amit Rood, Mark Martyn, Trejeeve Rose, Susannah Rothberg, Michael B. J Gen Intern Med Original Research BACKGROUND: The coronavirus disease 2019 pandemic has contributed to growing demand for mental health services, but patients face significant barriers to accessing care. Direct-to-consumer(DTC) telemedicine has been proposed as one way to increase access, yet little is known about its pre-pandemic use for mental healthcare. OBJECTIVE: To characterize patients, providers, and their use of a large nationwide DTC telemedicine platform for mental healthcare. DESIGN: Retrospective cross-sectional study. SETTING: Mental health encounters conducted on the American Well DTC telemedicine platform from 2016 to 2018. PARTICIPANTS: Patients and physicians. MAIN MEASURES: Patient measures included demographics, insurance report, and number of visits. Provider characteristics included specialty, region, and number of encounters. Encounter measures included wait time, visit length and timing, out-of-pocket payment, coupon use, prescription outcome, referral receipt, where care otherwise would have been sought, and patient satisfaction. Factors associated with five-star physician ratings and prescription receipt were assessed using logistic regression. KEY RESULTS: We analyzed 19,270 mental health encounters between 6708 patients and 1045 providers. Visits were most frequently for anxiety (39.1%) or depression (32.5%), with high satisfaction (4.9/5) across conditions. Patients had a median 2.0 visits for psychiatry (IQR 1.0–3.0) and therapy (IQR 1.0–5.0), compared to 1.0 visit (IQR 1.0–1.0) for urgent care. High satisfaction was positively correlated with prescription receipt (OR 1.89, 95% CI 1.54–2.32) and after-hours timing (aOR 1.18, 95% CI 1.02–1.36). Prescription rates ranged from 79.6% for depression to 32.2% for substance use disorders. Prescription receipt was associated with increased visit frequency (aOR 1.95, 95% CI 1.57–2.42 for ≥ 3 visits). CONCLUSIONS: As the burden of psychiatric disease grows, DTC telemedicine offers one solution for extending access to mental healthcare. While most encounters were one-off, evidence of some continuity in psychiatry and therapy visits—as well as overall high patient satisfaction—suggests potential for broader DTC telemental health use. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11606-021-07326-y. Springer International Publishing 2022-01-29 2022-08 /pmc/articles/PMC8799413/ /pubmed/35091925 http://dx.doi.org/10.1007/s11606-021-07326-y Text en © The Author(s) under exclusive licence to Society of General Internal Medicine 2022 |
spellingShingle | Original Research Hohman, Jessica A. Martinez, Kathryn A. Anand, Amit Rood, Mark Martyn, Trejeeve Rose, Susannah Rothberg, Michael B. Use of Direct-to-Consumer Telemedicine to Access Mental Health Services |
title | Use of Direct-to-Consumer Telemedicine to Access Mental Health Services |
title_full | Use of Direct-to-Consumer Telemedicine to Access Mental Health Services |
title_fullStr | Use of Direct-to-Consumer Telemedicine to Access Mental Health Services |
title_full_unstemmed | Use of Direct-to-Consumer Telemedicine to Access Mental Health Services |
title_short | Use of Direct-to-Consumer Telemedicine to Access Mental Health Services |
title_sort | use of direct-to-consumer telemedicine to access mental health services |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8799413/ https://www.ncbi.nlm.nih.gov/pubmed/35091925 http://dx.doi.org/10.1007/s11606-021-07326-y |
work_keys_str_mv | AT hohmanjessicaa useofdirecttoconsumertelemedicinetoaccessmentalhealthservices AT martinezkathryna useofdirecttoconsumertelemedicinetoaccessmentalhealthservices AT anandamit useofdirecttoconsumertelemedicinetoaccessmentalhealthservices AT roodmark useofdirecttoconsumertelemedicinetoaccessmentalhealthservices AT martyntrejeeve useofdirecttoconsumertelemedicinetoaccessmentalhealthservices AT rosesusannah useofdirecttoconsumertelemedicinetoaccessmentalhealthservices AT rothbergmichaelb useofdirecttoconsumertelemedicinetoaccessmentalhealthservices |